glp-1 anhedonia Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 Drug Improved Motivation in

If GLP-1 agonists show superior neuroprotective benefits, this could challenge the traditional treatment paradigm and support initiating therapy with GLP-1 agonists in selected patients. GLP-1 agonists have demonstrated mechanisms that include reducing neuroinflammation, enhancing cerebral glucose metabolism, and improving synaptic plasticity, Wu added

Oral ingestion of both concentrations of collagen peptides increased the water content of the SC and decreased TEWL

gut of our time

The AHK-Cu peptide complete guide covers the current state of research and how this peptide differs from its more established cousin

Diabetes promotes development of CVD, and at least two classes of diabetes medications have been shown to improve CVD outcomes in patients with diabetes